Major venture capital investment in European life sciences will fuel occupier market
MGI estimates big savings from LS research practices
Artificial Intelligence In Drug Discovery
The Coming Age for Tech x Bio: The “Industrial Bio Complex”
VC Firms Have Long Backed AI. Now, They Are Using It.
CapitalVX: A machine learning model for startup selection and exit prediction
Exscientia Files For $100M IPO
New records were set in a huge quarter for global & US funding, exits, valuations, and more.
Europe’s Early-Stage Life Sciences Venture Capitalists Unveil Advocacy Organisation to Drive Innovation and Investment in Health Care
Morocco’s Mohammed VI Polytechnic University and ALPHA10X Sign Research and Development Partnership Agreement
3 Myths About Women Working in Tech, Busted
ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie
